Cambridge’s history of 450 years is no doubt considered by many of the 7 million tourists who visit the city each year.
Investors’ association with Cambridge has been more recent with the announcement of Astra Zeneca’s relocation to the city as an HQ in 2013. The Government’s recognition of Cambridge as a centre of excellence for R&D technology and life science has attracted companies such Napp Pharmaceuticals, Amgen and Microsoft. Cambridge’s tight land supply and often very protracted planning process have restricted the supply of office accommodation within the city. This has created an environment for steady rental performance but also limited the supply of opportunities for investors.
Investors want to be part of a major epicentre of the UK’s technological and tech industry hub which with the University, have helped create Cambridge’s brand.
MacLaren & Partners have acted for clients in Cambridge since 2013, and have since transacted over £120M and advised on asset management solutions too. The business has built a strong reputation for performance amongst a network of local landowners.
MacLaren believe that Cambridge will continue to have an enduring appeal to investors as the local economy grows and attracts companies to expand using the talented pool of graduates.